A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration

Suddhasil Mookherjee, Holly Yu Chen, Kevin Isgrig, Wenhan Yu, Suja Hiriyanna, Rivka Levron, Tiansen Li, Peter Colosi, Wade W Chien, Anand Swaroop, Zhijian Wu

Research output: Contribution to journalArticle

Abstract

Mutations in CEP290 cause ciliogenesis defects, leading to diverse clinical phenotypes, including Leber congenital amaurosis (LCA). Gene therapy for CEP290-associated diseases is hindered by the 7.4 kb CEP290 coding sequence, which is difficult to deliver in vivo. The multi-domain structure of the CEP290 protein suggests that a specific CEP290 domain may complement disease phenotypes. Thus, we constructed AAV vectors with overlapping CEP290 regions and evaluated their impact on photoreceptor degeneration in Cep290rd16/rd16 and Cep290rd16/rd16;Nrl−/− mice, two models of CEP290-LCA. One CEP290 fragment (the C-terminal 989 residues, including the domain deleted in mutant mice) reconstituted CEP290 function and resulted in cone preservation and delayed rod death. The CEP290 C-terminal domain also improved cilia phenotypes in mouse embryonic fibroblasts and iPSC-derived retinal organoids carrying the Cep290rd16 mutation. Our study strongly argues for in trans complementation of CEP290 mutations by a cognate fragment and suggests therapeutic avenues. CEP290 mutations are the leading cause of Leber congenital amaurosis, a devastating inherited blindness. Mookherjee et al. show that the in-frame deletion of Cep290 in rd16 mice can be complemented by expressing a cognate protein fragment in trans, suggesting a new avenue for therapy development of CEP290 mutations.

Original languageEnglish (US)
Pages (from-to)611-623.e6
JournalCell Reports
Volume25
Issue number3
DOIs
StatePublished - Oct 16 2018
Externally publishedYes

Fingerprint

Retinal Degeneration
Leber Congenital Amaurosis
Gene therapy
Mutation
Fibroblasts
Cones
Proteins
Phenotype
Defects
Organoids
Cilia
Blindness
Genetic Therapy
Therapeutics

Keywords

  • AAV
  • CEP290
  • ciliopathy
  • gene therapy
  • LCA
  • photoreceptors
  • retinal degeneration

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mookherjee, S., Chen, H. Y., Isgrig, K., Yu, W., Hiriyanna, S., Levron, R., ... Wu, Z. (2018). A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration. Cell Reports, 25(3), 611-623.e6. https://doi.org/10.1016/j.celrep.2018.09.043

A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration. / Mookherjee, Suddhasil; Chen, Holly Yu; Isgrig, Kevin; Yu, Wenhan; Hiriyanna, Suja; Levron, Rivka; Li, Tiansen; Colosi, Peter; Chien, Wade W; Swaroop, Anand; Wu, Zhijian.

In: Cell Reports, Vol. 25, No. 3, 16.10.2018, p. 611-623.e6.

Research output: Contribution to journalArticle

Mookherjee, S, Chen, HY, Isgrig, K, Yu, W, Hiriyanna, S, Levron, R, Li, T, Colosi, P, Chien, WW, Swaroop, A & Wu, Z 2018, 'A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration', Cell Reports, vol. 25, no. 3, pp. 611-623.e6. https://doi.org/10.1016/j.celrep.2018.09.043
Mookherjee, Suddhasil ; Chen, Holly Yu ; Isgrig, Kevin ; Yu, Wenhan ; Hiriyanna, Suja ; Levron, Rivka ; Li, Tiansen ; Colosi, Peter ; Chien, Wade W ; Swaroop, Anand ; Wu, Zhijian. / A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration. In: Cell Reports. 2018 ; Vol. 25, No. 3. pp. 611-623.e6.
@article{b0ca1347cc0549abb8b147b192e22a7d,
title = "A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration",
abstract = "Mutations in CEP290 cause ciliogenesis defects, leading to diverse clinical phenotypes, including Leber congenital amaurosis (LCA). Gene therapy for CEP290-associated diseases is hindered by the 7.4 kb CEP290 coding sequence, which is difficult to deliver in vivo. The multi-domain structure of the CEP290 protein suggests that a specific CEP290 domain may complement disease phenotypes. Thus, we constructed AAV vectors with overlapping CEP290 regions and evaluated their impact on photoreceptor degeneration in Cep290rd16/rd16 and Cep290rd16/rd16;Nrl−/− mice, two models of CEP290-LCA. One CEP290 fragment (the C-terminal 989 residues, including the domain deleted in mutant mice) reconstituted CEP290 function and resulted in cone preservation and delayed rod death. The CEP290 C-terminal domain also improved cilia phenotypes in mouse embryonic fibroblasts and iPSC-derived retinal organoids carrying the Cep290rd16 mutation. Our study strongly argues for in trans complementation of CEP290 mutations by a cognate fragment and suggests therapeutic avenues. CEP290 mutations are the leading cause of Leber congenital amaurosis, a devastating inherited blindness. Mookherjee et al. show that the in-frame deletion of Cep290 in rd16 mice can be complemented by expressing a cognate protein fragment in trans, suggesting a new avenue for therapy development of CEP290 mutations.",
keywords = "AAV, CEP290, ciliopathy, gene therapy, LCA, photoreceptors, retinal degeneration",
author = "Suddhasil Mookherjee and Chen, {Holly Yu} and Kevin Isgrig and Wenhan Yu and Suja Hiriyanna and Rivka Levron and Tiansen Li and Peter Colosi and Chien, {Wade W} and Anand Swaroop and Zhijian Wu",
year = "2018",
month = "10",
day = "16",
doi = "10.1016/j.celrep.2018.09.043",
language = "English (US)",
volume = "25",
pages = "611--623.e6",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration

AU - Mookherjee, Suddhasil

AU - Chen, Holly Yu

AU - Isgrig, Kevin

AU - Yu, Wenhan

AU - Hiriyanna, Suja

AU - Levron, Rivka

AU - Li, Tiansen

AU - Colosi, Peter

AU - Chien, Wade W

AU - Swaroop, Anand

AU - Wu, Zhijian

PY - 2018/10/16

Y1 - 2018/10/16

N2 - Mutations in CEP290 cause ciliogenesis defects, leading to diverse clinical phenotypes, including Leber congenital amaurosis (LCA). Gene therapy for CEP290-associated diseases is hindered by the 7.4 kb CEP290 coding sequence, which is difficult to deliver in vivo. The multi-domain structure of the CEP290 protein suggests that a specific CEP290 domain may complement disease phenotypes. Thus, we constructed AAV vectors with overlapping CEP290 regions and evaluated their impact on photoreceptor degeneration in Cep290rd16/rd16 and Cep290rd16/rd16;Nrl−/− mice, two models of CEP290-LCA. One CEP290 fragment (the C-terminal 989 residues, including the domain deleted in mutant mice) reconstituted CEP290 function and resulted in cone preservation and delayed rod death. The CEP290 C-terminal domain also improved cilia phenotypes in mouse embryonic fibroblasts and iPSC-derived retinal organoids carrying the Cep290rd16 mutation. Our study strongly argues for in trans complementation of CEP290 mutations by a cognate fragment and suggests therapeutic avenues. CEP290 mutations are the leading cause of Leber congenital amaurosis, a devastating inherited blindness. Mookherjee et al. show that the in-frame deletion of Cep290 in rd16 mice can be complemented by expressing a cognate protein fragment in trans, suggesting a new avenue for therapy development of CEP290 mutations.

AB - Mutations in CEP290 cause ciliogenesis defects, leading to diverse clinical phenotypes, including Leber congenital amaurosis (LCA). Gene therapy for CEP290-associated diseases is hindered by the 7.4 kb CEP290 coding sequence, which is difficult to deliver in vivo. The multi-domain structure of the CEP290 protein suggests that a specific CEP290 domain may complement disease phenotypes. Thus, we constructed AAV vectors with overlapping CEP290 regions and evaluated their impact on photoreceptor degeneration in Cep290rd16/rd16 and Cep290rd16/rd16;Nrl−/− mice, two models of CEP290-LCA. One CEP290 fragment (the C-terminal 989 residues, including the domain deleted in mutant mice) reconstituted CEP290 function and resulted in cone preservation and delayed rod death. The CEP290 C-terminal domain also improved cilia phenotypes in mouse embryonic fibroblasts and iPSC-derived retinal organoids carrying the Cep290rd16 mutation. Our study strongly argues for in trans complementation of CEP290 mutations by a cognate fragment and suggests therapeutic avenues. CEP290 mutations are the leading cause of Leber congenital amaurosis, a devastating inherited blindness. Mookherjee et al. show that the in-frame deletion of Cep290 in rd16 mice can be complemented by expressing a cognate protein fragment in trans, suggesting a new avenue for therapy development of CEP290 mutations.

KW - AAV

KW - CEP290

KW - ciliopathy

KW - gene therapy

KW - LCA

KW - photoreceptors

KW - retinal degeneration

UR - http://www.scopus.com/inward/record.url?scp=85054724115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054724115&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.09.043

DO - 10.1016/j.celrep.2018.09.043

M3 - Article

C2 - 30332642

AN - SCOPUS:85054724115

VL - 25

SP - 611-623.e6

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 3

ER -